RWE saw the highest growth of 5.99% in patent filings in June and 0.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.49% and grants by 0.99%. GlobalData’s DataBook provides a comprehensive analysis of RWE’s patent filings and grants. Buy the databook here.
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
RWE has been focused on protecting inventions in European Patent Office(EPO) with eight publications in Q2 2024
The European Patent Office(EPO) Patent Office dominates the patent filings and grants with nearly 35% filings and 25% grants. The Germany(DE), European Patent Office(EPO), United States(US), and World Intellectual Property Organization(WIPO) patent Office are among the top ten patent offices where RWE is filings its patents. Among the top granted patent authorities, RWE has 50% of its grants in United States(US), 25% in European Patent Office(EPO) and 25% in Spain(ES).
Vestas Wind Systems and Siemens Energy could be the strongest competitors for RWE
Patents related to microgrids and solar lead RWE's portfolio
RWE has the highest number of patents in microgrids followed by, solar and climate change. For microgrids, nearly 40% of patents were filed and 9% of patents were granted in Q2 2024.
Distribution related patents lead RWE portfolio followed by automobile batteries, and energy infrastructure
RWE has highest number of patents in distribution followed by automobile batteries, energy infrastructure, solar pv, and offshore wind power. For distribution, nearly 19% of patents were filed and 8% of patents were granted in Q2 2024.
For comprehensive analysis of RWE's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

